Veru (VERU) Total Non-Current Liabilities (2011 - 2026)
Veru (VERU) posted Total Non-Current Liabilities of $8.06 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 12.2% from $9.18 million a year earlier but up 8.2% from the prior quarter.
Veru (VERU) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Veru's Total Non-Current Liabilities came in at $10.14 million, down 57.1% from FY2024.
- Annual Total Non-Current Liabilities has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -13.9% (FY2020 to FY2025).
- In prior fiscal years, Veru's Total Non-Current Liabilities was $23.64 million in FY2024 (-22.0%), $30.31 million in FY2023 (-42.3%), $52.54 million in FY2022 (+122.5%) and $23.61 million in FY2021 (+10.3%).
- Quarterly Total Non-Current Liabilities has run from a low of $7.45 million in fiscal Q2 2026 to a high of $52.54 million in fiscal Q4 2022 over five years.
- On a year-over-year basis, Total Non-Current Liabilities increased in 1 of the last seven quarters, with an average decline of 31.3%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q4 2022, with growth of 122.5%; the weakest was fiscal Q2 2025, with a decline of 61.8%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $7.45 million (Q2 2026), $9.34 million (Q1 2026) and $10.14 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Veru | 61.31 Mn | -48.96 Mn | - | 8.06 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.06 Mn |
| Mar 31, 2026 | 7.45 Mn |
| Dec 31, 2025 | 9.34 Mn |
| Sep 30, 2025 | 10.14 Mn |
| Jun 30, 2025 | 9.18 Mn |
| Mar 31, 2025 | 8.26 Mn |
| Dec 31, 2024 | 9.12 Mn |
| Sep 30, 2024 | 23.64 Mn |
| Jun 30, 2024 | 22.27 Mn |
| Mar 31, 2024 | 21.60 Mn |
| Sep 30, 2023 | 30.31 Mn |
| Jun 30, 2023 | 39.52 Mn |
| Mar 31, 2023 | 48.49 Mn |
| Dec 31, 2022 | 52.06 Mn |
| Sep 30, 2022 | 52.54 Mn |
| Jun 30, 2022 | 43.69 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Dec 31, 2021 | 24.15 Mn |
| Sep 30, 2021 | 23.61 Mn |
| Jun 30, 2021 | 25.09 Mn |
Veru Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VERU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();